Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation

NCT00563589 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Graft vs Host Disease
Hematopoietic Stem Cell Transplantation

Interventions

DRUG: mycophenolate mofetil, methotrexate, cyclosporin
DRUG: Methotrexate and cyclosporin

Sponsor

Hospital Authority, Hong Kong

Collaborators

[object Object]